News Release 2019

• November 19, 2019

  NHI Drug Price Listing and Release of Oral Quinolone Antibacterial Agent "Lasvic®Tablets 75mg"

• November 7, 2019

  KYORIN and JEIL Signed License Agreement for Vibegron in Korea

• October 29, 2019

  Release of Microchannel-based Genetic Measurement Device GeneSoC®

• October 28, 2019

  Resumption of Supply of Desalex® Tablets 5mg Long-Acting Selective H1 Receptor Antagonist for Allergic Diseases Treatment

• September 20, 2019

  Kyorin Pharmaceutical Receives Marketing Approval for Oral Quinolone Antibacterial Agent "Lasvic®Tablets 75mg"

• August 23, 2019

  Release of Mometasone Nasal 50μg「KYORIN」56sprays, 112sprays

• May 13, 2019

  Kyorin Signed Memorandum of Understanding on Marketing Collaboration with respect to Chronic Cough Treatment

• January 7, 2019

  Impact on Kyorin's Financial Performance of MSD's Decision to Voluntarily Recall Desalex® Tablets 5mg Long-Acting Selective H1 Receptor Antagonist for Allergic Diseases Treatment

• 1